Form4insider filings, from the source

SEC Form 4 · accession 0000950103-18-013358

CASI Pharmaceuticals, Inc. · CASI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Fei Yang
10% Owner
SNOW MOON LTD
10% Owner
Jianguang Li
10% Owner
Dongliang Lin
10% Owner
Hugo Shong
10% Owner
Period of report
Nov 13, 2018
Accepted (ET)
Nov 14, 2018 · 6:04 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 13, 2018X1,699,753$1.69A10,198,518D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantF1$1.69Nov 13, 2018X948,982DApr 15, 2016Apr 15, 2019Common Stock948,9820D
WarrantF1$1.69Nov 13, 2018X750,771DSep 23, 2016Sep 23, 2019Common Stock750,7710D

Explanation of responses